133 related articles for article (PubMed ID: 27941815)
1. Association between neutrophil-to-lymphocyte ratio and differentiated thyroid cancer: a meta-analysis.
Liu JF; Ba L; Lv H; Lv D; Du JT; Jing XM; Yang NJ; Wang SX; Li C; Li XX
Sci Rep; 2016 Dec; 6():38551. PubMed ID: 27941815
[TBL] [Abstract][Full Text] [Related]
2. Delta Neutrophil Index and Neutrophil-to-Lymphocyte Ratio in the Differentiation of Thyroid Malignancy and Nodular Goiter.
Bozan MB; Yazar FM; Kale İT; Yüzbaşıoğlu MF; Boran ÖF; Azak Bozan A
World J Surg; 2021 Feb; 45(2):507-514. PubMed ID: 33067685
[TBL] [Abstract][Full Text] [Related]
3. Sequential Analysis of Neutrophil-to-lymphocyte Ratio for Differentiated Thyroid Cancer Patients Treated With Lenvatinib.
Fukuda N; Wang X; Ohmoto A; Urasaki T; Sato Y; Nakano K; Nishizawa M; Yunokawa M; Ono M; Tomomatsu J; Takahashi S
In Vivo; 2020; 34(2):709-714. PubMed ID: 32111774
[TBL] [Abstract][Full Text] [Related]
4. May the neutrophil/lymphocyte ratio be a predictor in the differentiation of different thyroid disorders?
Kocer D; Karakukcu C; Karaman H; Gokay F; Bayram F
Asian Pac J Cancer Prev; 2015; 16(9):3875-9. PubMed ID: 25987053
[TBL] [Abstract][Full Text] [Related]
5. Blood neutrophil-to-lymphocyte ratio correlates with tumor size in patients with differentiated thyroid cancer.
Liu CL; Lee JJ; Liu TP; Chang YC; Hsu YC; Cheng SP
J Surg Oncol; 2013 Apr; 107(5):493-7. PubMed ID: 22996403
[TBL] [Abstract][Full Text] [Related]
6. The Time Series Behavior of Neutrophil-to-Lymphocyte Ratio in Thyroid Cancer Patients on Tyrosine Kinase Inhibitor Therapy.
Tomoda C; Sugino K; Kitagawa W; Nagahama M; Ito K
ORL J Otorhinolaryngol Relat Spec; 2021; 83(5):347-353. PubMed ID: 33735904
[TBL] [Abstract][Full Text] [Related]
7. An Increased Neutrophil-to-Lymphocyte Ratio Predicts Incomplete Response to Therapy in Differentiated Thyroid Cancer.
Lee F; Yang PS; Chien MN; Lee JJ; Leung CH; Cheng SP
Int J Med Sci; 2018; 15(14):1757-1763. PubMed ID: 30588200
[No Abstract] [Full Text] [Related]
8. The diagnostic predictive value of neutrophil-to-lymphocyte ratio in thyroid cancer adjusted for tumor size.
Cheong TY; Hong SD; Jung KW; So YK
PLoS One; 2021; 16(5):e0251446. PubMed ID: 33974674
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil to Lymphocyte Ratio is Useful in Differentiation of Malign and Benign Thyroid Nodules.
Sit M; Aktas G; Erkol H; Yaman S; Keyif F; Savli H
P R Health Sci J; 2019 Mar; 38(1):60-63. PubMed ID: 30924917
[TBL] [Abstract][Full Text] [Related]
10. Preoperative systemic inflammatory markers as prognostic factors in differentiated thyroid cancer: a systematic review and meta-analysis.
Russo E; Guizzardi M; Canali L; Gaino F; Costantino A; Mazziotti G; Lania A; Uccella S; Di Tommaso L; Ferreli F; Malvezzi L; Spriano G; Mercante G
Rev Endocr Metab Disord; 2023 Dec; 24(6):1205-1216. PubMed ID: 37828383
[TBL] [Abstract][Full Text] [Related]
11. The Neutrophil-to-Lymphocyte Ratio Correlates with Age in Patients with Papillary Thyroid Carcinoma.
Liu J; Du J; Fan J; Liu K; Zhang B; Wang S; Wang W; Wang Z; Cai Y; Li C; Yu T; Zhu G; Chen J; Li C
ORL J Otorhinolaryngol Relat Spec; 2015; 77(2):109-16. PubMed ID: 25896501
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of the efficacy of the pretreatment neutrophil-to-lymphocyte ratio as a predictor of prognosis in renal carcinoma patients receiving tyrosine kinase inhibitors.
Na N; Yao J; Cheng C; Huang Z; Hong L; Li H; Qiu J
Oncotarget; 2016 Jul; 7(28):44039-44046. PubMed ID: 27270655
[TBL] [Abstract][Full Text] [Related]
13. Clinical and prognostic value of neutrophil-lymphocyte ratio for patients with thyroid cancer: A meta-analysis.
Feng J; Wang Y; Shan G; Gao L
Medicine (Baltimore); 2020 May; 99(20):e19686. PubMed ID: 32443286
[TBL] [Abstract][Full Text] [Related]
14. Prognostic importance of baseline neutrophil to lymphocyte ratio in patients with advanced papillary thyroid carcinomas.
Kim JY; Park T; Jeong SH; Jeong CY; Ju YT; Lee YJ; Hong SC; Ha WS; Choi SK; Jung EJ
Endocrine; 2014 Aug; 46(3):526-31. PubMed ID: 24272600
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the correlation of neutrophil/lymphocyte ratio with prognostic classification systems in papillary thyroid carcinoma patients.
Yildiz EO; Işcen K; Kaya F; Güney OA; Ulukent SC
Medicine (Baltimore); 2024 Feb; 103(5):e37210. PubMed ID: 38306518
[TBL] [Abstract][Full Text] [Related]
16. The significance of neutrophil/lymphocyte ratio as a possible marker of underlying papillary microcarcinomas in thyroidal goiters: a pilot study.
Seretis C; Gourgiotis S; Gemenetzis G; Seretis F; Lagoudianakis E; Dimitrakopoulos G
Am J Surg; 2013 Jun; 205(6):691-6. PubMed ID: 23388425
[TBL] [Abstract][Full Text] [Related]
17. Effect of hypertension on preoperative neutrophil-lymphocyte ratio evaluation of prognosis of renal cell carcinoma.
Sun J; Ning H; Sun J; Qu X
Urol Oncol; 2016 May; 34(5):239.e9-15. PubMed ID: 26803433
[TBL] [Abstract][Full Text] [Related]
18. Prognostic role of neutrophil-to-lymphocyte ratio in aortic disease: a meta-analysis of observational studies.
Xu Y; Fang H; Qiu Z; Cheng X
J Cardiothorac Surg; 2020 Aug; 15(1):215. PubMed ID: 32778122
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of neutrophil-to-lymphocyte ratio in patients with metastatic renal cell carcinoma treated with first-line and subsequent second-line targeted therapy: A proposal of the modified-IMDC risk model.
Tanaka N; Mizuno R; Yasumizu Y; Ito K; Shirotake S; Masunaga A; Ito Y; Miyazaki Y; Hagiwara M; Kanao K; Mikami S; Nakagawa K; Momma T; Masuda T; Asano T; Oyama M; Oya M
Urol Oncol; 2017 Feb; 35(2):39.e19-39.e28. PubMed ID: 27825515
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of neutrophil lymphocyte ratio in patients with gastric cancer: a meta-analysis.
Zhang X; Zhang W; Feng LJ
PLoS One; 2014; 9(11):e111906. PubMed ID: 25401500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
